Literature DB >> 15707970

Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction.

Makiko Inaba1, Hiroshi Saito, Minoru Fujimoto, Satoru Sumitani, Tomoharu Ohkawara, Toshio Tanaka, Haruhiko Kouhara, Soji Kasayama, Ichiro Kawase, Tadamitsu Kishimoto, Tetsuji Naka.   

Abstract

Suppressor of cytokine signaling (SOCS) 1 was initially identified as an intracellular negative feedback regulator of the JAK-STAT signal pathway. Recently, it has been suggested that SOCS1 affects signals of growth factors and hormones. One of them, SOCS1, is also known to be involved in auto-regulation of IRS-1-mediated signaling. However, the mechanism(s) of SOCS1 induction by insulin-like growth factor (IGF)-I and a role of SOCS1 on IGF-I receptor-mediated signaling are not clarified. Here, we investigate SOCS1 on muscle differentiation. We found that muscle differentiation was suppressed in SOCS1 stable transformant C2C12 myoblasts, while it was promoted in SOCS1-deficient myoblasts. Additionally, SOCS1 augmented MEK phosphorylation and reduced Akt phosphorylation induced by IGF-I. Then, SOCS1 stable transformant C2C12 myoblasts, infected with adenovirus bearing constitutively active Akt, have the ability to differentiate again. Collectively, these findings suggest that SOCS1 suppresses muscle differentiation through negative feedback regulation of IGF-I receptor-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707970     DOI: 10.1016/j.bbrc.2005.01.046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  SOCS2 inhibited mitochondria biogenesis via inhibiting p38 MAPK/ATF2 pathway in C2C12 cells.

Authors:  Lu Gan; Zhenjiang Liu; Zhenzhen Zhang; Xiaobo Yang; Jing Liu; Chao Sun
Journal:  Mol Biol Rep       Date:  2013-12-19       Impact factor: 2.316

2.  Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling.

Authors:  Claudia A Nold-Petry; Marcel F Nold; Jason W Nielsen; Alex Bustamante; Jarod A Zepp; Kathleen A Storm; Jae-Woo Hong; Soo-Hyun Kim; Charles A Dinarello
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

3.  Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt.

Authors:  Chun-Jie Gao; Pei-Jun Ding; Li-Li Yang; Xu-Feng He; Meng-Jiao Chen; Dong-Ming Wang; Yan-Xin Tian; Hui-Min Zhang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 4.  An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system.

Authors:  Benjamin Lant; Kenneth B Storey
Journal:  Int J Biol Sci       Date:  2010-01-07       Impact factor: 6.580

5.  SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway.

Authors:  Yarui Diao; Xi Wang; Zhenguo Wu
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

6.  Maternal dietary restriction during the periconceptional period in normal-weight or obese ewes results in adrenocortical hypertrophy, an up-regulation of the JAK/STAT and down-regulation of the IGF1R signaling pathways in the adrenal of the postnatal lamb.

Authors:  Song Zhang; Janna L Morrison; Amreet Gill; Leewen Rattanatray; Severence M MacLaughlin; David Kleemann; Simon K Walker; I Caroline McMillen
Journal:  Endocrinology       Date:  2013-10-09       Impact factor: 4.736

Review 7.  JAK-STAT pathway and myogenic differentiation.

Authors:  You-Na Jang; Eun Joo Baik
Journal:  JAKSTAT       Date:  2013-04-01

8.  SOCS-3 inhibits E2F/DP-1 transcriptional activity and cell cycle progression via interaction with DP-1.

Authors:  Yoshikazu Masuhiro; Kenichi Kayama; Akie Fukushima; Koji Baba; Makio Soutsu; Yoshiaki Kamiya; Michio Gotoh; Noboru Yamaguchi; Shigemasa Hanazawa
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.